Patel Sanj K
Reporting owner on Forms 3, 4 and 5, CIK 1532218.
Patel Sanj K reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-06.
Issuers
| Issuer | Roles in the latest filing | Filings | Last filed |
|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals International, plcCIK 1730430 | director, officer (CHAIRMAN & CEO) | 2 | 2026-11-06 |
Transactions and holdings
Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.
| Security | Date | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-04 | M exercised | +145,763 | $17.92 | 925,800 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-04 | S sold | -1,460 | $92.35 | 924,340 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-04 | S sold | -11,335 | $93.54 | 913,005 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-04 | S sold | -81,742 | $94.2 | 831,263 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-04 | S sold | -29,845 | $95.48 | 801,418 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-04 | S sold | -26,918 | $96.05 | 774,500 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding | 92,348 | Form 4 | ||||
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding | 109,795 | Form 4 | ||||
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-04 | M exercised | -145,763 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-03 | M exercised | +89,089 | $8.83 | 958,970 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-03 | M exercised | +41,237 | $17.92 | 1,000,207 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-03 | S sold | -1,214 | $90.77 | 998,993 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-03 | S sold | -68,664 | $92.7 | 930,329 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-03 | S sold | -145,708 | $93.53 | 784,621 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-03 | S sold | -4,584 | $94.25 | 780,037 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-03 | M exercised | -89,089 | $0 | 0 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-03 | M exercised | -41,237 | $0 | 145,763 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | M exercised | +53,381 | $8.83 | 959,314 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -38,364 | $91.03 | 920,950 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -24,188 | $91.83 | 896,762 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -26,781 | $93.06 | 869,981 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-11-02 | S sold | -100 | $93.97 | 869,881 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-11-02 | M exercised | -53,381 | $0 | 89,089 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | M exercised | +47,530 | $8.83 | 999,324 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -41,169 | $92.01 | 958,155 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -18,685 | $92.77 | 939,470 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -15,903 | $93.62 | 923,567 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -8,888 | $94.72 | 914,679 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -4,490 | $95.97 | 910,189 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -2,316 | $97.34 | 907,373 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share | 2026-10-30 | S sold | -1,440 | $98.16 | 905,933 | Form 4 |
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding | 76,174 | Form 4 | ||||
| KNSA · Kiniksa Pharmaceuticals Int…Class A Ordinary Share, holding | 109,795 | Form 4 | ||||
| KNSA · Kiniksa Pharmaceuticals Int…Share Option, derivative | 2026-10-30 | M exercised | -47,530 | $0 | 142,470 | Form 4 |
Filings
The person's Forms 3, 4 and 5, and any 13D or 13G naming it.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| Form 4 0001532218-26-000020 | Kiniksa Pharmaceuticals International, plc | 2026-11-06 | ||
| Form 4 0001532218-26-000018 | Kiniksa Pharmaceuticals International, plc | 2026-11-03 |